González-Moro, A.; Valencia, I.; Shamoon, L.; Sánchez-Ferrer, C.F.; Peiró, C.; de la Cuesta, F.
NLRP3 Inflammasome in Vascular Disease: A Recurrent Villain to Combat Pharmacologically. Antioxidants 2022, 11, 269.
https://doi.org/10.3390/antiox11020269
AMA Style
González-Moro A, Valencia I, Shamoon L, Sánchez-Ferrer CF, Peiró C, de la Cuesta F.
NLRP3 Inflammasome in Vascular Disease: A Recurrent Villain to Combat Pharmacologically. Antioxidants. 2022; 11(2):269.
https://doi.org/10.3390/antiox11020269
Chicago/Turabian Style
González-Moro, Ainara, Inés Valencia, Licia Shamoon, Carlos Félix Sánchez-Ferrer, Concepción Peiró, and Fernando de la Cuesta.
2022. "NLRP3 Inflammasome in Vascular Disease: A Recurrent Villain to Combat Pharmacologically" Antioxidants 11, no. 2: 269.
https://doi.org/10.3390/antiox11020269
APA Style
González-Moro, A., Valencia, I., Shamoon, L., Sánchez-Ferrer, C. F., Peiró, C., & de la Cuesta, F.
(2022). NLRP3 Inflammasome in Vascular Disease: A Recurrent Villain to Combat Pharmacologically. Antioxidants, 11(2), 269.
https://doi.org/10.3390/antiox11020269